Shares Held (Direct Ownership) 145K
n/a 3M change
n/a 12M change
Total Value Held N/A

Ivan Hyep Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 09 2025
SELL
Open market or private sale
$116,945 $18.23 p/Share
6,415 Reduced 4.23%
145,355 Common Stock
Oct 09 2025
BUY
Exercise of conversion of derivative security
$24,312 $3.79 p/Share
6,415 Added 4.06%
151,770 Common Stock
Oct 08 2025
SELL
Open market or private sale
$102,467 $18.21 p/Share
5,627 Reduced 3.73%
145,355 Common Stock
Oct 08 2025
BUY
Exercise of conversion of derivative security
$21,326 $3.79 p/Share
5,627 Added 3.59%
150,982 Common Stock
Oct 07 2025
SELL
Open market or private sale
$332,405 $18.22 p/Share
18,244 Reduced 11.15%
145,355 Common Stock
Oct 07 2025
BUY
Exercise of conversion of derivative security
$69,144 $3.79 p/Share
18,244 Added 10.03%
163,599 Common Stock
Oct 06 2025
SELL
Open market or private sale
$118,359 $18.17 p/Share
6,514 Reduced 4.29%
145,355 Common Stock
Oct 06 2025
BUY
Exercise of conversion of derivative security
$24,688 $3.79 p/Share
6,514 Added 4.11%
151,869 Common Stock
IH

Ivan Hyep

Chief Financial Officer
Boston, MA

Track Institutional and Insider Activities on BCAX

Follow Bicara Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCAX shares.

Notify only if

Insider Trading

Get notified when an Bicara Therapeutics Inc. insider buys or sells BCAX shares.

Notify only if

News

Receive news related to Bicara Therapeutics Inc.

Track Activities on BCAX